Pharmaceuticals and Clinical Research converge at the forefront of medical innovation, intertwining to advance healthcare through scientific inquiry and evidence-based practices. The pharmaceutical industry is the engine driving drug discovery, development, and production, aiming to deliver safe and effective medications to address diverse health needs.
Clinical research plays a pivotal role in this journey, conducting systematic investigations to assess the safety, efficacy, and real-world impact of pharmaceutical interventions. Rigorous clinical trials, involving human participants, form the backbone of this research, generating data that informs healthcare decisions and regulatory approvals.
Pharmaceuticals and Clinical Research collectively contribute to the evolution of personalized medicine, tailoring treatments to individual patient characteristics. This dynamic relationship fosters the discovery of novel therapeutic agents, from small molecules to biologics, ushering in an era of targeted and precision medicine.
Pharmaceuticals and Clinical Research are inseparable partners, navigating the complex terrain of medical science to enhance patient outcomes, elevate standards of care, and shape the future of medicine.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India